FDA Recalls Blood Pressure Medication due to Potential Cancer Risks.
The Food and Drug Administration (FDA) is recalling Irbesartan, a blood pressure medication, due to a cancer risk. The FDA says the medication contains an ingredient that poses a cancer risk.
When testing the drug, the FDA found an organic chemical called, N-nitrosodiethylamine (NDEA). The chemical is classified as a probable human carcinogen which is used to make liquid rocket fuel and is also a byproduct of fish processing. It is also used in the manufacturing...